抗肿瘤药物相关口腔黏膜炎的发病机制与中医药防治研究

Research on the Pathogenesis and Traditional Chinese Medicine Prevention and Treatment of Anti-tumor Drug-Related Oral Mucositis

  • 摘要: 抗肿瘤药物相关口腔黏膜炎(ADOM)是肿瘤治疗中剂量限制性不良反应,多表现为黏膜溃疡、疼痛,严重者影响患者生活质量和治疗进程。ADOM发病机制因抗肿瘤药药物类型而异,涉及炎症因子失调、口腔菌群失调、免疫应答失衡等多种机制相互作用。在中医药防治方面,中药提取物/单药与复方通过抗炎、抗氧化、免疫调节等多靶点作用机制,可有效改善ADOM患者的黏膜情况。本文通过系统梳理ADOM的发病机制,并从中药单体或提取物、中药复方靶向通路总结中医药防治ADOM的研究进展,以期为ADOM的临床防治提供理论依据和治疗策略。

     

    Abstract: Anti-tumor drug-related oral mucositis (ADOM) is a dose-limiting adverse reaction in tumor treatment, which is characterized by mucosal ulcer and pain. In severe cases, it affects the quality of life and treatment process of patients. The pathogenesis of ADOM varies with the type of anti-tumor drugs, involving the interaction of various mechanisms such as inflammatory factor imbalance, oral flora imbalance, and immune response imbalance. In the prevention and treatment of traditional Chinese medicine, traditional Chinese medicine extract/single drug and compound can effectively improve the mucosal condition of ADOM patients through multi-target mechanisms such as anti-inflammation, anti-oxidation and immune regulation. Based on a systematic review of the modern pathogenesis of ADOM, this paper summarizes the research progress of traditional Chinese medicine in the prevention and treatment of ADOM from the targeted signaling pathways of Chinese herbal monomers, extracts and compound prescriptions, aiming to provide theoretical basis and therapeutic strategies for the clinical prevention and treatment of ADOM.

     

/

返回文章
返回